Production (Stage)
Knight Therapeutics Inc.
GUD.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.52M | 7.67M | 62.30K | -1.42M | -3.37M |
| Total Depreciation and Amortization | 8.07M | 9.32M | 9.82M | 9.62M | 9.33M |
| Total Amortization of Deferred Charges | -- | 662.90K | -- | -- | -- |
| Total Other Non-Cash Items | 995.00K | -7.88M | 1.86M | -278.40K | 5.44M |
| Change in Net Operating Assets | -8.03M | -8.72M | -8.06M | -8.72M | 11.50M |
| Cash from Operations | 2.56M | 1.05M | 3.68M | -793.70K | 22.91M |
| Capital Expenditure | -259.90K | -400.00K | -274.20K | -502.80K | -673.50K |
| Sale of Property, Plant, and Equipment | 20.90K | 71.40K | -- | 2.20K | 43.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.62M | 13.22M | 8.73M | 9.09M | -17.44M |
| Cash from Investing | 22.38M | 12.89M | 8.45M | 8.59M | -18.07M |
| Total Debt Issued | 1.81M | 543.00K | 1.64M | 747.00K | 545.00K |
| Total Debt Repaid | -2.71M | -7.97M | -3.04M | -7.91M | -2.61M |
| Issuance of Common Stock | 114.00K | 140.00K | 448.00K | 340.00K | 74.00K |
| Repurchase of Common Stock | -3.35M | -5.15M | -2.47M | -1.24M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -569.00K | -2.92M | -503.00K | -3.30M | -905.00K |
| Cash from Financing | -3.27M | -10.97M | -2.88M | -8.30M | -2.15M |
| Foreign Exchange rate Adjustments | 663.30K | 1.56M | 243.40K | -974.20K | 338.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.33M | 4.54M | 9.49M | -1.48M | 3.02M |